Curcumin and diabetes: a systematic review
- PMID: 24348712
- PMCID: PMC3857752
- DOI: 10.1155/2013/636053
Curcumin and diabetes: a systematic review
Abstract
Turmeric (Curcuma longa), a rhizomatous herbaceous perennial plant of the ginger family, has been used for the treatment of diabetes in Ayurvedic and traditional Chinese medicine. The active component of turmeric, curcumin, has caught attention as a potential treatment for diabetes and its complications primarily because it is a relatively safe and inexpensive drug that reduces glycemia and hyperlipidemia in rodent models of diabetes. Here, we review the recent literature on the applications of curcumin for glycemia and diabetes-related liver disorders, adipocyte dysfunction, neuropathy, nephropathy, vascular diseases, pancreatic disorders, and other complications, and we also discuss its antioxidant and anti-inflammatory properties. The applications of additional curcuminoid compounds for diabetes prevention and treatment are also included in this paper. Finally, we mention the approaches that are currently being sought to generate a "super curcumin" through improvement of the bioavailability to bring this promising natural product to the forefront of diabetes therapeutics.
Figures
References
-
- Shapiro K, Gong WC. Natural products used for diabetes. Journal of the American Pharmaceutical Association. 2002;42(2):217–226. - PubMed
-
- Gobert CP, Duncan AM. Consumption, perceptions and knowledge of soy among adults with type 2 diabetes. Journal of the American College of Nutrition. 2009;28(2):203–218. - PubMed
-
- Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. The Lancet. 2011;378(9786):169–181. - PubMed
-
- Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: the Indian solid gold. Advances in Experimental Medicine and Biology. 2007;595:1–75. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
